LOGIN  |  REGISTER
Terns Pharmaceuticals

Oscar Health to Present at Upcoming Healthcare Conferences

August 22, 2024 | Last Trade: US$18.34 0.25 1.38

NEW YORK / Aug 22, 2024 / Business Wire / Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, today announced its leaders will present and provide a business update at three upcoming healthcare conferences:

  • 2024 Wells Fargo Healthcare Conference: Chief Financial Officer, Scott Blackley, will participate in a fireside chat at approximately 12:45 p.m. ET on September 4, 2024.
  • Morgan Stanley 22nd Annual Global Healthcare Conference: Chief Executive Officer, Mark Bertolini, will participate in a fireside chat at approximately 1:50 p.m. ET on September 5, 2024.
  • Baird 2024 Global Healthcare Conference: Chief Financial Officer, Scott Blackley, will participate in a fireside chat at approximately 2:35 p.m. ET on September 11, 2024.

All interested parties are invited to listen to a live webcast by visiting ir.hioscar.com and selecting the “Events & Presentations” link. Following each presentation, a webcast replay will be available on Oscar’s investor relations website for 90 days.

About Oscar Health

Oscar Health, Inc. (“Oscar”) is a leading healthcare technology company built around a full stack technology platform and a relentless focus on serving our members. We have been challenging the status quo in the healthcare system since our founding in 2012, and are dedicated to making a healthier life accessible and affordable for all. Oscar offers Individual & Family plans and health technology solutions that power the healthcare industry through +Oscar. Our technology drives superior experiences, deep engagement, and high-value clinical care, earning us the trust of approximately 1.6 million members, as of June 30, 2024.

For more information, please visit www.hioscar.com.

C4 Therapeutics

Stock Quote

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page